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Maternal factors introduced into host insects by endo-
parasitoid wasps are usually essential for successful
parasitism. This includes polydnaviruses (PDVs) that
are produced in the reproductive organ of female hym-
enopteran endoparasitoids and are injected, together
with venom proteins, into the host hemocoel at oviposi-
tion. Inside the host, PDVs enter various tissue cells and
hemocytes where viral genes are expressed, leading to
developmental and physiological alterations in the host,
including the suppression of the host immune system.
Although several studies have shown that some PDVs
are only effective when accompanied by venom pro-
teins, there is no report of an active venom ingredient(s)
facilitating PDV infection and/or gene expression. In
this study, we describe a novel peptide (Vn1.5) isolated
from Cotesia rubecula venom that is required for the
expression of C. rubecula bracoviruses (CrBVs) in host
hemocytes (Pieris rapae), although it is not essential for
CrBV entry into host cells. The peptide consists of 14
amino acids with a molecular mass of 1598 Da. In the
absence of Vn1.5 or total venom proteins, CrBV genes
are not expressed in host cells and did not cause inacti-
vation of host hemocytes.
Endoparasitoid wasps oviposit their eggs inside the hemo-
coel of other insects, where their progeny is exposed to host
defense reactions, which include humoral and cellular re-
sponses. Endoparasitoids have evolved effective mechanisms
for successful parasitism that allow them to evade or inhibit
the host immune responses (1). Maternal factors are intro-
duced into the host hemocoel, together with eggs, during ovi-
position. These factors include symbiotic PDVs,1 calyx, and
venom proteins (2–4) and may act alone or in conjunction with
one or more of the other factors. Inhibition of insect immune
responses may involve one or more pathways, such as changes
in hemocyte population, down-regulation of phenoloxidase ac-
tivity, and aberrant hemocyte morphologies (4, 5).
Polydnaviruses associated with hymenopteran parasitoid
families Ichneumonidae and Braconidae are referred to as ich-
noviruses and bracoviruses (6, 7). The particles are only pro-
duced in the female reproductive tract and are released into the
oviduct lumen and injected at oviposition into the host hemo-
coel, where virus genes are expressed in the absence of viral
DNA replication (8, 9). Virions are able to enter many host cell
types (10, 11). Viral transcripts are detected within a few hours
following parasitization, and viral genes are either expressed
transiently or persistently (10, 12). The presence of PDVs has
been shown to be essential for successful parasitism and devel-
opment of parasitoids inside their hosts (2, 13, 14). When
parasitoid eggs devoid of PDVs are artificially injected into the
host hemocoel, the host insect displays a cellular immune re-
sponse against large exogenous objects that encapsulates the
eggs (2).
In endoparasitoids without PDVs, venom proteins, produced
by a pair of specialized glands associated with the female
reproductive organ, seem to play a major role in host immune
suppression and host regulation. For example, in Pimpla hy-
pochondriaca (Braconidae), venom adversely affects the mor-
phology, viability, and immune function of hemocytes of the
tomato moth, Lacanobia oleracea (15, 16). Venom proteins also
cause developmental alterations in the host. Venom from
Aphidius ervi (Braconidae) causes castration of female Acyrtho-
siphon pisum aphids (17). In Galleria mellonella, venom from
Microplitis croceipes reduces larval growth (18). In addition, it
has been shown that, in certain cases, venom might have a
potent immune-suppressive activity, impairing hemocyte-me-
diated immune responses before the expression of PDVs
or interfering with the activation of the host hemolymph
phenoloxidase (18–22).
In some parasitoid systems, PDVs are only effective in con-
junction with venom proteins. For example, in Cotesia glom-
eratus (23) and Apanteles kariyai (24), venom is an essential
requirement for successful parasitism. In Cotesia melanoscela,
it is reported that venom proteins promote the release of viri-
ons into the cytoplasm after uptake by host cells, facilitating
the uncoating of PDVs at nuclear pores in host hemocytes (25).
In addition, venom proteins enhance virus persistence in the
host.
Four genes from Cotesia rubecula bracoviruses (CrBVs) have
been found to be expressed in the host Pieris rapae, designated
as CrV1–4 (12). They are abundantly expressed in various host
tissues, providing active protection by suppressing host cellular
responses (26, 27). A 32-kDa protein associated with particles
is produced in calyx cells and covers the eggs of the parasitoid,
providing passive immune protection while CrBV genes are
expressed (28, 29). Several novel proteins have been isolated
from C. rubecula venom and found to provide immune protec-
tion by inhibiting the activation of host hemolymph pro-
phenoloxidase and melanin formation (20–22). However, there
is little known about the functional relationship between
CrBVs and venom proteins in this host-parasitoid system.
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In the present study, we found that venom proteins are
essential for the expression of CrBV genes in host cells,
although not required for virus entry. A novel venom pep-
tide consisting of 14 amino acids with a molecular mass of
1598 Da (Vn1.5) was found to be sufficient for CrBV gene
expression in host cells. In the absence of Vn1.5, CrBV gene
transcription was not detected, and hemocyte behavior
was not changed, despite the entrance of viruses into the
cells.
EXPERIMENTAL PROCEDURES
Insect Cultures—The endoparasitoid wasps, C. rubecula (Hym-
enoptera: Braconidae) and its host insect were maintained at 25 °C, on
a 14:10 hour (light:dark) photoperiod. P. rapae (Lepidoptera: Pieridae)
larvae were reared on cabbage plants. Adult wasps were fed with
honey-water solution (28).
Bracovirus Isolation—CrBVs were purified from newly emerged fe-
male wasps as described previously (30). Briefly, isolated ovaries were
macerated in PBS (138 mM NaCl, 2.7 mM KCl, 1.47 mM KH2PO4, and 7.3
mM Na2HPO4, pH 7.4) by using micro-scissors. The suspension was
centrifuged at 750  g for 5 min to exclude large cellular debris. The
homogenate was then passed through a 0.45-m syringe filter (Mini-
start®) and centrifuged at 15,800  g in a desktop centrifuge for 20
min. The pelleted virus particles were resuspended in PBS.
Reverse Phase High Pressure Liquid Chromatography—Venom res-
ervoirs from 50 female C. rubecula wasps were dissected and disrupted
in PBS by micro-scissors to release venom proteins into the buffer
solution. Reverse phase high pressure liquid chromatography
(rpHPLC) of samples was carried out in a Hewlett Packard 1090 liquid
chromatograph. The crude venom sample was loaded onto a Vydac
reverse phase C18 column and eluted at the flow rate of 0.2 ml/min
using a gradient of 5–100% of buffer B (0.04% trifluoroacetic acid in 70%
acetonitrile) against buffer A (0.05% trifluoroacetic acid in water) over
82 min. The collected fractions were detected by absorbance at 214 nm,
and protein fractions were collected manually. For in vitro hemocyte
infection assays (see below), individual fractions were vacuum-dried
and dissolved in sterile water.
Mass Spectrometry—To determine the molecular mass of venom
peptides, electrospray ionization mass spectrometry was carried out by
using a PE Sciex API-100. Generally, an amount equivalent to 7 pmol
of purified protein was directly infused, and the resulting raw data were
analyzed using the BioMultiView 3.1.1 software.
Peptide Sequencing—Approximately 100 pmol of the purified pep-
tides from rpHPLC was vacuum-dried, reconstituted in 8 M urea con-
taining 0.1 M NH4HCO3 and 4 mM dithiothreitol, and finally alkylated
by the addition of sodium iodoacetate to the final concentration of 10
mM. The sample was acidified with trifluoroacetic acid to stop the
reaction. Peptide sequencing was carried out using a Hewlett Packard
G1000A protein sequencer.
FIG. 1. Effect of venom on expression of CrV1. P. rapae hemo-
cytes were allowed to attach for 10 min. CrBVs from 2 wasp equivalents
were added to the medium and incubated at 25 °C for an additional 6 h
in the absence or presence of total C. rubecula venom proteins (1 wasp
equivalent). The cells were collected by centrifugation as described
under “Experimental Procedures.” Total RNA was extracted, and 2 g
of RNA for each sample was used for RT-PCR analysis (A) with primers
specific to CrV1 (arrow) and slot blot hybridization (B) using CrV1 and
P. rapae 18 S rRNA as probes. No CrV1 expression was detected in the
absence of venom. Cells inoculated with purified particles without
(CrBV) and with total venom proteins (CrBVVn) are shown. M, DNA
molecular weight marker; Par, RNA from 6-h-parasitised hemocytes.
FIG. 2. Venom protein separation
and Vn1.5 and Vn1.6 sequences. A,
separation of crude C. rubecula venom
proteins on rpHPLC. Twelve main pro-
teins or peptides were divided into three
groups (a, b, and c). Group a included
fractions 1–4; group b, fractions 5–8; and
group c included fractions 9–12. B, amino
acid sequence of fraction 1 (Vn1.5 peptide)
obtained from N-terminal microsequenc-
ing. C, amino acid sequence of fraction 2
(Vn1.6 peptide) obtained from N-terminal
microsequencing.
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Peptide Vn1.5 Synthesis—Vn1.5 was synthesized by Auspep Pty. Ltd.
and analyzed by mass spectral analysis for molecular weight and pu-
rity. The lyophilized peptide was reconstituted in sterile water. Various
concentrations of the peptide were used in CrBV infection of hemocytes
(see below).
CrBV Infection of Hemocytes in Vitro—Fourth instar P. rapae larvae
were surface sterilized in 70% ethanol and bled into cold PBS (saturated
with 1-phenyl-2-thiourea to prevent melanization) by removing one of
the forelegs. Hemocytes were collected by centrifuging the hemolymph
at 750  g for 5 min and removing the serum. The cells were resus-
pended in 100 l of HyQ-SFX insect cell culture medium (HyClone) per
insect, bled, and transferred into a 24-well tissue culture plate. 200 l
of the cell suspension containing 500 cells were allowed to attach for
about half an hour at room temperature. Purified CrBVs, equivalent of
two wasps, were added to each well. In different treatments, total
venom proteins, individual peptides, or mixtures of purified peptides
were also added to the cells and mixed by gently pipetting up and down.
The cells were incubated for an additional 6 h at 25 °C, after which they
were collected by resuspending the cells in the medium and centrifug-
ing at 750  g for 5 min. Total RNA was then isolated from the cells for
reverse transcription-PCR or slot blot assays.
DNA and RNA Isolation—DNA was isolated from cells by homoge-
nization in a Tris buffer containing 10 mM Tris, 10 mM EDTA, and 1%
SDS, pH 8.0. Proteinase K was added to a final concentration of 0.25
g/l. The samples were incubated at 37 °C overnight and then treated
with RNase A at 37 °C for an additional 30 min. The samples were
extracted with phenol/chloroform, and then 2 volumes of ethanol and
0.2 volume of 3 M sodium acetate (pH 5.3) were added to precipitate the
DNA. The mixtures were incubated on wet ice for 15 min and centri-
fuged at 15,800  g for 20 min. Pellets were washed with 70% ethanol,
dried at 37 °C for 5 min, and resuspended in 30 l of water. Total RNA
was isolated from hemocytes as described by Ausubel et al. (31).
Reverse Transcription-PCR (RT-PCR)—Two pairs of primers
(CrV1-F and CrV1-R (12) and CrV2-F and CrV2-R (32)) specific to the
two CrBV genes, CrV1 and CrV2, were used in reverse transcription
reactions using avian myeloblastosis virus reverse transcriptase. In a
total volume of 10.7 l, 2 g of extracted RNA plus 0.1 g of primer was
heated at 95 °C for 5 min to denature RNA before being cooled imme-
diately on ice. After that, 3 l of 5 avian myeloblastosis virus reverse
transcription buffer, 0.5 l of avian myeloblastosis virus reverse tran-
scriptase (9 units/l, Promega), 0.5 l of RNasin (40 units/l) and 0.5 l
of deoxynucleotide triphosphates (15 mM) were added. The reactions
were carried out at 42 °C for 1 h followed by 95 °C for 5 min to inactivate
the reverse transcriptase. The resulting DNA fragments were then used
in a PCR amplification by adding 5 l of 10 reaction buffer, 1 l of
forward primer (0.1 g/l), 1 l of reverse primer (0.1 g/l), 0.5 l of
deoxynucleotide triphosphates (15 mM), 2.5 units of Taq DNA polymer-
ase (Promega) and 27.5 l of H2O. After 5 min at 94 °C, 35 amplification
cycles were run, including denaturing at 94 °C for 50 s, annealing at
56 °C for 50 s, and extension at 72 °C for 1.5 min. The final extension at
72 °C was carried out for 10 min. All reaction products were electro-
phoresed on 1% agarose gels and visualized by using ethidium bromide.
DNA and RNA Slot Blot Hybridization—DNA or RNA samples were
blotted onto a nylon membrane (Amersham Biosciences) under dena-
turing conditions according to the manufacturer’s instructions (Bio-
Rad). The blots were prehybridized and then hybridized with 32P-
FIG. 3. Assay of virus functions. Effect of rpHPLC-isolated venom
proteins on CrBV expression of CrV1 (arrows) in P. rapae hemocytes
using RT-PCR and RNA slot blot hybridization. P. rapae hemocytes
were allowed to attach for 10 min and were then incubated with puri-
fied CrBVs in the absence (C) or presence of purified venom protein
fractions (see Fig. 2) for an additional 6 h at 25 °C. The cells were
collected, and total RNA was extracted as described under “Experimen-
tal Procedures.” A, mixture of 12 fractions (M12), representing proteins
from the total venom, was used for the assay. 2 g of RNA was used for
RT-PCR analyses using CrV1-specific primers. B, mixtures of groups a
(M1), b (M2), and c (M3) (see Fig. 2) were used for the assays. 2 g of
RNA for each sample was used for RT-PCR using CrV1-specific primers.
M, DNA molecular weight marker; Par, RNA from 6-h-parasitised
hemocytes. C, venom fractions 1–4 from group a purified by rpHPLC
were used individually for the assays, and RNA from cells were ana-
lyzed by slot blot hybridization. Blots containing 3 g of RNA were
hybridized with a CrV1 cDNA fragment as a probe. A control blot was
probed with a P. rapae 18 S ribosomal DNA fragment (r18S) to monitor
that similar amounts of RNA had been loaded for each sample. Mix,
mixture of the four fractions in lanes 1–4.
FIG. 4. Effect of synthesized peptide
Vn1.5 on the expression of CrV1. Vi-
rus gene expression was monitored by
RT-PCR and RNA slot blot hybridization.
A, hemocytes were incubated with puri-
fied CrBVs in the absence (CrBV) or pres-
ence of various concentrations of synthe-
sized Vn1.5 or total venom proteins (Vn)
for 6 h. Hemocytes from parasitized lar-
vae were used as a positive control (Par).
2 g of RNA for each sample was used for
RT-PCR using primers specific to CrV1
(arrow). B, 3.2 g of RNA was loaded
onto each slot and probed with a 32P-la-
beled cDNA fragment encoding CrV1. A
control blot was probed with a P. rapae 18
S ribosomal DNA fragment (r18S) to mon-
itor that similar amounts of RNA had
been loaded for each sample.
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labeled PCR products encoding CrV1 (900 bp) and CrV2 (900 bp) at
65 °C overnight. For RNA slot blots, a P. rapae ribosomal 18 S DNA
fragment probe was used as a control.
Hemocyte Behavior Changes after CrBV Infection with or without
Vn1.5—Hemocytes were collected as described above and resuspended
in 120 l of HyQ-SFX insect cell culture medium (HyClone) per insect
equivalent. 30 l of a cell suspension containing 80 cells was trans-
ferred into each well of a multiwell plate and incubated for 10 min to
allow the cells to attach. Four treatments were set up by adding the
following ingredients to the cell monolayers: 1) purified CrBVs and
synthesized Vn1.5, 2) CrBVs and total venom proteins, 3) CrBVs alone,
and 4) PBS. The cells were incubated for an additional 6 h at 25 °C,
fixed with 4% paraformaldehyde, and observed under a phase contrast
microscope.
Transmission Electronic Microscopy—Hemocyte monolayers were in-
oculated with purified CrBVs plus synthesized Vn1.5 or with CrBVs
alone as above for 2 h at 25 °C. The cells were then fixed overnight in 4%
glutaraldehyde (electron microscope grade) in PBS, with 4% sucrose at
pH 7.2. The cells were washed in PBS plus 4% sucrose (2 changes of
solution for 10 min each). The samples were post-fixed in 2% osmium
tetroxide (OsO4) for 1 h on a rotator and dehydrated in ethanol and
propylene oxide. The samples were embedded in resin, and micrographs
were taken by using a Jeol 1010 transmission electron microscope.
RESULTS
Venom Is Required for CrBV Gene Expression—To show
whether venom components are essential for CrBV gene ex-
pression in host cells, in vitro assays were carried out using
P. rapae hemocytes. Specific primers from the CrV1 coding
region, which is highly expressed in host hemocytes 6 h follow-
ing parasitization (12), were used as markers in RT-PCR reac-
tions. When hemocytes were infected with purified CrBV par-
ticles isolated from female wasps, no CrV1 transcripts were
detected in cells after 6 h (Fig. 1A). However, when CrBV
particles were added to cells together with venom fluid, CrV1
was expressed strongly (Fig. 1A). The results were confirmed
by three independent repeats of the experiment. In addition,
slot blot hybridization, using CrV1 cDNA as a probe, showed
that the gene is not expressed in inoculated hemocytes in the
absence of venom (Fig. 1B). This indicated that venom compo-
nents are required for CrBV gene expression of host cells,
although they are not essential for CrBV entry into host cells
(see below).
rpHPLC Separation of Venom Proteins and Bioassays—
When crude venom preparations from female C. rubecula en-
doparasitoids were fractionated on a rpHPLC column, more
than a dozen peptides and proteins were identified (Fig. 2A). To
examine which venom component(s) are involved in CrBV func-
tion, we collected 12 main fractions and arbitrarily divided the
fractions into three groups (Fig. 2A; a, 1–4; b, 5–8; and c, 9–12),
each containing four major fractions. The eluted proteins cor-
responding to each fraction were vacuum-dried and resus-
pended in sterile water. Proteins or peptides from each group
were mixed together (equivalent to two wasps) and applied
together with purified CrBV particles to hemocyte monolayers.
After 6 h, total RNA was isolated from the inoculated cells and
subjected to RT-PCR using CrV1-specific primers.
CrV1 transcripts were detected in inoculated cells when a
mixture of the 12 fractions was added together with purified
CrBVs (Fig. 3A). However, when a mixture of individual groups
was added together with purified CrBVs, CrV1 transcripts were
only found in group A and not in the other two groups (Fig. 3B).
Because component(s) required for CrBV infection are in group
A, individual fractions from this group were used in a subsequent
assay. CrV1 transcripts were found in cells infected with CrBVs
in the presence of fractions 1, 3, or 4 (Fig. 3C). All subsequent
experiments were performed with fraction 1.
Mass Spectrometry and Peptide Sequence Analyses—The size
of the peptide in fraction 1 isolated on rpHPLC (Fig. 2A) was
determined by mass spectrometry to be 1598 Da and desig-
nated Vn1.5. The peptide was also N-terminally sequenced,
providing 14 amino acids (Fig. 2B) with the predicted molecular
weight matching the mass of the peptide determined by mass
spectrometry. The estimated isoelectric point of Vn1.5 is 10.01.
The sequence of Vn1.5 was compared with other proteins and
peptides in protein databases, but no significant similarity was
found.
Attemps to N-terminally sequence fractions 2–4 only pro-
duced amino acid sequences in fraction 2. The other two frac-
tions might contain proteins/peptides that are N-terminally
blocked. Sequence analysis of fraction 2 produced 14 amino
acids (Fig. 2C) with the predicted molecular mass of 1640 Da
and a theoretical pI of 6.18. The mass of the peptide was
also analyzed by mass spectrometry and determined as 1640
Da, indicating that the sequence contained the full-length
sequence. We designated this peptide Vn1.6.
Effect of Synthetic Peptide Vn1.5 on the CrBV Gene Expres-
sion—To further confirm the function of Vn1.5 in CrBV gene
expression, the peptide was synthesized and used for in vitro
FIG. 5. CrV2 gene expression. Effect of synthesized Vn1.5 on the
expression of CrV2 in hemocytes by RT-PCR analyses. 1.2 g of RNA
was used for each reaction. CrV2 transcripts (arrow) were not detected
in cells infected with CrBVs alone. M, DNA molecular weight marker;
Par, RNA from 6-h-parasitised hemocytes; Vn, venom proteins.
FIG. 6. Effect of CrBVs on hemocyte
behavior in the presence or absence
of venom proteins. To collect hemo-
cytes, fourth instar larvae of P. rapae
were bled into PBS saturated with 1-phe-
nyl-2-thiourea followed by centrifugation
for 5 min at 750  g. The cells were re-
suspended in cell culture medium. 30 l
of the cell suspension was added per well
of a multiwell slide and incubated for 10
min to allow the cells to attach. Purified
CrBVs and synthesized Vn1.5 (1.5 g/ml)
were added and mixed gently. Mixtures
were incubated for an additional 6 h.
After that, hemocytes were fixed and
observed under a phase contrast
microscope.
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bioassays. Hemocytes were inoculated with purified CrBV par-
ticles in the presence or absence of synthetic Vn1.5. To examine
possible concentration dependence, three different magnitudes
of peptide concentrations 5 g/ml, 0.5 mg/ml, and 50 mg/ml
were applied. CrV1 transcripts were detected in treated cells at
all three concentrations (Fig. 4A). Although the intensity of
signals increased slightly with the increase in concentration
(Fig. 4), the difference in gene expression did not reflect three
magnitudes in peptide concentrations. These results further
confirmed that Vn1.5 alone was sufficient to promote the
expression of CrBV genes at low concentrations.
To examine whether other CrBV genes were also dependent
on the venom peptide for their expression, we used CrV2 coding
DNA as a probe. When CrV2-specific primers were used for
RT-PCR, CrV2 transcripts were also detected in the infected
cells in the presence of 1.5 g/ml Vn1.5 or total venom proteins
equivalent to one wasp (Fig. 5). Conversely, no transcript was
detected in cells inoculated with CrBVs alone.
Hemocyte Changes after CrBV Incubation with or without
Vn1.5—We have shown previously that CrBVs do not cause cell
death in host hemocytes (12, 26). The main effect observed in
hemocytes after parasitization and infection by CrBVs was a
breakdown of cell cytoskeleton, which precluded the spreading
and encapsulation responses. To further confirm the effect of
Vn1.5 on the expression of CrBV genes, hemocyte changes,
such as spreading behavior after CrBV infection with or with-
out the synthetic peptide, were investigated. When hemocytes
from P. rapae were incubated with purified CrBV particles or
Vn1.5 (1.5 g/ml) for 6 h, the cells spread and aggregated
extensively, similar to the control. However, when hemocytes
were incubated with a mixture of purified CrBV particles and
Vn1.5 for 6 h, the hemocytes were dispersed and spread less
frequently on the glass surface compared with the control (Fig.
6), which is reminiscent of the hemocyte behavior after natural
parasitization (12, 26). This further confirms the role of Vn1.5
in facilitating the expression of CrBV genes at the functional
level.
Electron Microscopy—To examine whether CrBV particles
are able to enter host cells in the absence of venom components,
hemocytes were inoculated with purified particles and the cy-
toplasm analyzed for the presence of electron-dense particles,
using transmission electron microscopy (Fig. 7). Under these
conditions, electron-dense particles are detected in endosomes,
free of membranes in the cytoplasm, and associated with nu-
clear membranes (Fig. 7B), similar to naturally infected hemo-
cytes (25). This implies that the peptide might be involved in
chromatin restructuring or uncoating of the virus genome at
the nuclear membrane. Alternatively, the peptide may be re-
quired for viral gene expression at the transcriptional level (e.g.
as a transcription factor). Further investigations are required
to elucidate the exact mechanism by which Vn1.5 facilitates
CrBV gene expression in host cells.
DISCUSSION
In contrast to insect ectoparasitoid-host interactions, where
venom has a paralyzing function, venom has a different func-
tion in endoparasitoids, where it is mainly involved in alter-
ations of host physiology. In addition, depending on whether or
not endoparasitoids produce virus-like particles, such as PDVs,
venom may complement or replace PDV functions in host reg-
ulation. For example, venom from P. hypochondriaca (Bra-
conidae), which seems to lack any virus-like particles, ad-
versely affects the morphology, viability, and the immune
function of hemocytes of the tomato moth, Lacanobia oleracea
(16). In endoparasitoids with PDVs, a combination of maternal
factors suppresses host immune responses, and venom proteins
play a synergistic role with PDVs (23–25,33). In C. melanos-
cela, total venom was found to promote the release of virions
into the cytoplasm of infected host cells and enhanced persist-
ence of the virus in the host (25).
In C. rubecula, maternal factors introduced into the body of
the host at oviposition are essential for successful completion of
parasitism. An immunosuppressive gene (CrV1) from C. rube-
cula bracoviruses is involved in the destabilization of cytoskel-
FIG. 7. Transmission electron microscopy of P. rapae cells in-
cubated with purified CrBVs. Cells were incubated with the virus in
the absence of venom proteins for 2 h. Cells are shown at lower (A) and
higher (B) magnifications. Large numbers of electron-dense virus par-
ticles were found in the cytoplasm either within endosomes (white
arrow) or released into the cytoplasm (black arrow), and some associ-
ated with the nuclear membrane. N, nucleus. Similar observations were
made when CrBV particles were accompanied with total venom or
Vn1.5 (not shown). No apparent differences are observed with naturally
infected hemocytes. C, an uninfected hemocyte.
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eton in host hemocytes (12, 26). In addition, a calyx protein
(Crp32) on the surface of CrBV particles and eggs provides
short term protection against host encapsulation reactions be-
fore CrBV genes are expressed (28, 29). When crude venom
preparations isolated from female C. rubecula endoparasitoid
wasps were separated by rpHPLC, over a dozen proteins were
found, some of which are involved in the inhibition of melaniza-
tion by blocking the activation of prophenoloxidase (20–22).
In the present study, we explored the interaction between
venom proteins and CrBVs with regard to virus entry and gene
expression. When P. rapae hemocytes were incubated with
CrBVs in vitro in the presence or absence of venom proteins,
viral transcripts were only detected in infected cells in conjunc-
tion with venom proteins. It is clear that venom is required for
CrBV expression in host cells, although electron microscopy
observations revealed that venom components were not essen-
tial for CrBV entry into host cells. Using various mixtures of
venom proteins separated on rpHPLC, we found that a
1598-Da peptide (Vn1.5) was sufficient for the expression of
CrBV genes when used together with purified particles in in
vitro assays. However, another peptide from C. rubecula venom
consisting of 14 amino acids and a molecular mass of 1640 Da
(Vn1.6) did not support expression of CrBV genes. Considering
that the peptide is similar in size to Vn1.5, this indicates that
only specific peptides are able to support the expression of
CrBV genes. Vn1.5 is basic and hydrophobic, whereas Vn1.6 is
acidic. These or other biochemical properties of Vn1.5 might
contribute to its ability to facilitate CrBV expression. In addi-
tion to Vn1.5, two other fractions were also found to equally
promote expression of viral genes. Whether these fractions
contain proteins/peptides that have biochemical properties
similar to Vn1.5 that facilitate the expression of CrBV genes
remains to be investigated.
Synthetic Vn1.5 peptides in conjunction with purified virus
were shown to facilitate the expression of CrBV genes, whereas
synthetic peptides or CrBV particles alone were not able to
cause behavioral changes in hemocytes. This suggests that
calyx-derived virus particles and venom-derived Vn1.5 pep-
tides are both required to express CrBV genes in host hemo-
cytes, similar to natural parasitism (12, 26).
Transmission electron microscopy observations showed that
venom proteins, including Vn1.5, are not required for the virus
entry, release into the cytoplasm from endosomes, or attach-
ment to the nuclear membrane of CrBVs. This suggests that
the peptide might facilitate virus chromatin restructuring, un-
coating of genomic DNA at the nuclear pore, or expression of
CrBV genes at transcriptional level. Further investigations are
required to elucidate the exact involvement of Vn1.5 and per-
haps other venom proteins in facilitating the expression of
polydnaviral genes. However, this is the first report of the
characterization of a venom peptide from an endoparasitoid
wasp involved in promoting the expression of polydnavirus
genes at the molecular and functional level.
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